@CanesDavid@AmrElbakryUro I found an email confirming I got the Merrell Encore Gust in 2011, and now 15 years later just started the Gust 2. Though that does not mean I should have waited that long lol.
1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026.
I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most.
For 33 years, PCF has brought science and lived experience together to move research forward.
#PCFRetreat26
Oral boards prep hasn't appreciably changed in decades, so I built MockUro, an AI examiner that walks you through ~250 canonical urology cases in Socratic Q&A format, grades your free-form answers across key domains, and adapts your study plan to your weak spots
🧵
@qdtrinh Can you differentiate partial gland (FT) from whole gland ablation in NCDB? I thought "local tumor destruction" can be whole gland or FT.
Perhaps minor 2010-2012 LR/FIR downtick from less whole gland while 2022-2023 uptick from FT. 2023 Ns by risk cat may be more true FT use.
@LauraBukavinaMD Lol why were they allowed to conjecture about complex cases being first as a caveat rather than the main finding.
Need data on last case outcomes stratied by surgeons needing to get to a kids sports game or not.
@NCSAUA Board Member Dr. James Brown and the section's Early Career Investigators Showcase nominees @Dr_i_pp_olito and @HitenDPatel selected for presentation at #AUA26.
New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: https://t.co/A1RikB7ZIo
#AUA26 is just 4 days away!
@NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world.
Meet our representatives and follow along for conference updates!
🔥 POISE-3 Urology published in European Urology 🚨
In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis
More at https://t.co/Yypy7vb9Jz
#EBM